Skip to content

Public FDA record

Z-2517-2021: Sight OLO-E1/U1 Software and Operators Manual Software v2.56.1 Catalog #: 1 OLO-U1 Catalog #: 2 OLO-E1

Recall record Z-2517-2021 for SIGHT DIAGNOSTICS LTD. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2517-2021
Company in FDA record
SIGHT DIAGNOSTICS LTD
FDA record creation date
Sep 22, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Discrepancy in labeling between the adult CBC reference ranges presented in the OLO Operator's Manual and the OLO software

Source facts

Action
Sight Diagnosics issued URGENT 2021-03-16 Medical Device Recall Notification on 3/15/21 via email. Letter states reason for recall, health risk and action to take: Corrective and Preventive Actions Taken by the Company: Section 5.7.1 of both OLO-E1 and OLO-U1 Operator s Manuals has been updated to reflect the adult reference ranges verified by Sight. Software version v2.56.1 was updated to software version v2.56.2, which is configured (by default) with the adult reference ranges verified by Sight. Actions to be taken by the customer: Please discard all previous Operator's Manuals in your possession. Attached to this recall notification is the OLO Operators Manual, rev. 1.14 (U1) and 1.15 (E1). The updated Operator's Manual includes Sights verified reference ranges. Each laboratory should either validate these ranges or establish their own in accordance with their state and regulatory agency guidelines. The software version of the OLO analyzer in your possession will be updated to a new version that includes the above mentioned correction. The update will be performed remotely by Sight's product specialists, who will contact you in the coming month to schedule the update. Please be aware that the software version update requires the analyzer to be connected to the internet. If you are a distributor, please provide a copy of this recall notification and updated Operator s Manual to any customer whom the product was shipped to, or may have been shipped to. If you have been authorised by Sight to translate the Operator s Manual, please make sure you update the Operator s Manual s translation accordingly. You are kindly requested to fill the attached Acknowledgement and Receipt Form, and return it to Sight notifications@sightdx.com within 30 days. If you are required to notify your local authority, please use this notification letter and inform Sight as soon as possible. If you have any questions please contact us at Support@sightdx.com. For full indicati
Initiated
2021-03-17
Root cause
Labeling Change Control
Terminated
2022-06-08
Distribution
Worldwide distribution - US Nationwide distribution in the states of Alabama, Florida, Massachusetts, Minnesota, Missouri, New York, Ohio, Texas, Virginia, Washington and the countries of AUSTRALIA, CHILE, UNITED KINGDOM, GEORGIA, ISRAEL, Mexico, NETHERLANDS, Portugal, Russia, Singapore, Thailand.
Recall number
Z-2517-2021
Recall status
Terminated
CDRH record ID
188581
FDA record created
2021-09-22
Recall event number
88401

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗